Dialysis
VIDEO: Value-based care models can benefit nephrology but must remain patient-centered
LONG BEACH, Calif. — Gaurav Jain, MD, of the University of Alabama at Birmingham discussed value-based care in nephrology at the National Kidney Foundation Spring Clinical Meetings, here.
Grub Club helps kids, families incorporate more ‘renal-friendly’ nutrition
LONG BEACH, Calif. — Off-unit sessions organized around games, resources, fresh food and meal preparation improved patient knowledge around nutrition and kidney disease, resulting in improved phosphorous levels.
Medical nutrition therapy seen as cost-effective, cost-saving method for late-stage CKD
LONG BEACH, Calif. — Implementing medical nutrition therapy for patients with late-stage chronic kidney disease saved an estimated $47,000 per patient by delaying the need for dialysis, according to a poster presented here.
Study finds clinicians do not consistently use algorithms when dosing Mircera
LONG BEACH, Calif. — Clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia, presented research shows.
Investigational drug that reduces hepcidin offers promise for treating anemia
LONG BEACH, Calif. — Researchers reported results from a phase 1b/2a placebo-controlled study of DISC-0974, an anti-hemojuvelin antibody to treat anemia in patients with chronic kidney disease.
Lisa Koester, ANP, CS, CNN-NP, MSN, receives Carol Mattix Award
The National Kidney Foundation has awarded Lisa Koester, ANP, CS, CNN-NP, MSN, the Carol Mattix Award at the NKF Spring Clinical Meetings in Long Beach, California.
‘Critical gap’ exists between recommended, prevalent nephrology practices
A “critical gap” between recommended and commonly used nephrology practices, including kidney replacement therapy-directed education, exists, according to a published study.
CMS releases proposed rule aimed at increasing efficiencies, access to kidney transplants
CMS and HHS have announced a proposed rule aimed at improving the performance of transplant centers and addressing disparities in access to kidney transplants.
Outset Medical receives FDA 510(k) clearance for TabloCart with Prefiltration
The FDA has granted Outset Medical Inc. 510(k) clearance of TabloCart with Prefiltration, an optional accessory for the Tablo Hemodialysis System, according to a press release.
Adverse drug reactions seen as ‘major cause of hospitalization’ in patients with CKD
Adverse drug reactions make up a major cause of hospitalization in patients with chronic kidney disease where lower eGFR is a risk factor, according to published data.